Press releases

- Alzheimer’s Research: Inflammatory Markers Are Conspicuous at an Early Stage

Symbolic image

Long before the onset of dementia, there is evidence for increased activity of the brain’s immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a study of more than 1,000 older adults.

Read more

- Around 1.5 Million Euros for Bonn Dementia Researcher

Symbolic images showing DNA data

Ahmad Aziz, scientist at DZNE’s Bonn site, has been awarded a “Starting Grant” from the European Research Council (ERC) worth around 1.5 million euros. With this funding, he aims to investigate the extent to which certain patterns in the genetic code contribute to the…

Read more

- Viral Infections Could Promote Neurodegeneration

Symbolic image of a virus

Some viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the scientific journal “Nature Communications” on the basis of laboratory experiments.

Read more

- Award for Cambridge Neuroscientist

Portrait Goeddert

Michel Goedert is honored for his groundbreaking research on the molecular mechanisms of neurodegenerative diseases.

Read more

- In Neurodegenerative Diseases, Brain Immune Cells Have a “Ravenous Appetite” for Sugar

Symbolic image of the human brain

The Interpretation of Certain Brain Scans Needs Rethinking – Study in „Science Translational Medicine“

Read more

- Researchers Find Warning Signs for Dementia in the Blood

Symbolic image of blood tubes

Levels of Certain microRNAs Indicate Risk for Cognitive Decline.

Read more

- „Tuning“ for Brain Scanners

Symbolic image of a brain scan.

DZNE coordinates international research project on Ultra-High Field MRI.

Read more

- How Environmental Factors Could Provide for a Young Brain

Symbol image of a DNA.

Study in “Nature Communications” on epigenetic mechanisms in the hippocampus.

 

Read more

- Smart Biomarkers to Empower Drug Development for Brain Diseases

Symbolic image

Dresden Researchers Awarded Prestigious Funding by the Helmholtz Association to Validate a Novel Approach that Combines Neuroelectronics and Artificial Intelligence.

Read more

- Alzheimer’s: U.S. Regulatory Authority Approves Use of “Aducanumab” on the Condition of Further Studies

Symbol image, not for editorial use.

Statement by Prof. Pierluigi Nicotera, Scientific Director and Chairman of the DZNE’s Executive Board.

 

Read more

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: